The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis is now available...see more
FDA Approves ACADIA Pharmaceuticals’ NUPLAZID™ (pimavanserin)
The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with...see more
Gene Therapy Prevents Parkinson’s Disease in Animal Model, Says Pitt Study
PITTSBURGH, June 15, 2015 – Gene therapy to...see more
April Parkinson’s Awareness Month Proclamation
Assemblywoman Malliotakis presents a Proclamation announcing April as “Parkinson’s Disease Awareness Month” to Leslie...see more
APDA Partners with BioMech to Raise Funds and Get Golfers With PD Back into the Swing
APDA Partners with BioMech to Raise Funds and Get Golfers With Parkinson’s Disease Back into the Swing People with...see more
APDA Is Proud To Join Parkinson’s Action Network’s Unified Partners Program
(New York, NY, June 3, 2015) – The...see more
APDA official charity of Rite Aid Cleveland Marathon 2015
American Parkinson Disease Association official charity of Rite Aid Cleveland Marathon 2015 The Rite Aid Cleveland Marathon named the...see more
APDA Awards More Than 1.1 Million to Research
The American Parkinson Disease Association (APDA), has awarded more than $1.1 million in seven research grants, four post-graduate fellowships,...see more
2013 – 2014 Grant Progress Updates
2013-2014 Grant Progress Updates September 2014 Research Grants Ming Guo, MD, PhD UCLA David Geffen School of Medicine Study...see more
First Steps Towards a Vaccine for Parkinson’s disease
By: Alice Lazzarini, PhD On July 31st, the Austrian biotech company,...see more